Guggenheim Maintains Buy on Neogen, Raises Price Target to $14

Guggenheim analyst Subbu Nambi has maintained a 'Buy' rating on Neogen (NASDAQ: NEOG) and raised the price target from $12 to $14. This adjustment reflects a positive outlook for the company in the market.